# Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

> **NCT01258088** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Plaque-type Psoriasis

## Interventions

- **DRUG:** AN2728 Ointment
- **DRUG:** AN2728 Vehicle

## Key facts

- **NCT ID:** NCT01258088
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-30
- **Primary completion:** 2010-12-07
- **Final completion:** 2010-12-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258088, "Safety Study of Ointment for the Treatment of Plaque-type Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01258088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*